Skip to main content
Equibles
HYPD logo

HYPD · Hyperion Defi, Inc.

Track HYPD — free

Use HYPD with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about HYPD

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$3.37 +0.11 (+3.37%)
Market Cap
$49.42M
Shares
15.54M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.26 Open$3.40 Day$3.24–3.50 52W close$2.34–14.98 Avg vol 30d337K Short int1.6M · 10.0% float · 6.4d Short vol50% Last earningsAug 12, 2026 DataFeb 2025–Aug 2026 Filing10-Q · Aug 13

Raw chart and full-history price indicators begin at the captured split on Feb 3, 2025; bars on opposite sides are not compared.

Up next

Next earnings call
Dec 2, 2026 Est · unconfirmed · in 14 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 13, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Neutral Sentiment Bullish Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 15.9 · calm Equity put/call 0.68
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −7%
      below
      Price vs 50-day avg +12%
      above
      RSI (14) 64
      neutral
      MACD trend Positive
      52-week position 7%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Neutral
      1-month return +27%
      trailing
      6-month return +8%
      trailing
      YTD return −8%
      this year
      Relative strength −4%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $3 › 200d $4 — 200d above 50d
      Institutional flow Accumulating
      +22% holders QoQ · +12 funds added
      Insider flow Accumulating
      Net +$29.6K over 90 days · 0% sells
      Short interest Rising
      10.04% of float · ▲ +1.8% MoM · 6.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      33 holders — near 1-yr high, broad support
      Squeeze score 72
      high risk · 0–100
      Fundamentals
      Strong
      Revenue growth +1319%
      Y/Y
      Gross margin 63%
      expanding
      EPS growth +84%
      Y/Y
      Free cash flow $-14.9M
      Balance sheet $1.5M
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 125%
      annualized · 1-yr
      Max drawdown −84%
      past year
      ATR 7.8%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Aug 12, 2026
      Adjusted gross profit · 2026 $5M – $7M
      Prior guidance period ended · from the 8-K filed Nov 13, 2025
      Adjusted Revenues · Q4'25 $475,000 – $515,000

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      2 · 3 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −7% Bearish
      Price vs 50-day avg
      +12% Bullish
      RSI (14)
      64 Neutral
      MACD trend
      Positive Bullish
      52-week position
      7% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $3 › 200d $4 — 200d above 50d
      Institutional flow Accumulating
      +22% holders QoQ · +12 funds added
      Insider flow Accumulating
      Net +$29.6K over 90 days · 0% sells
      Short interest Rising
      10.04% of float · ▲ +1.8% MoM · 6.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      33 holders — near 1-yr high, broad support
      Price context
      position in its 52-week range
      Range low $2 Now $3 · 7% Range high $15
      vs 200-day avg -7% vs 50-day avg +12%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      % Earned in Cash non-GAAP 50% Q2'26 —
      Adjusted Net Investing Cash Flow non-GAAP -$6,165,672 Q2 2026 —
      Adjusted Net Operating Cash Flow non-GAAP -$2,124,382 Q2 2026 —
      Ending Cash, Cash Equivalents, and Stablecoins non-GAAP $11,758,699 Q2 2026 —
      Gross HYPE Holdings non-GAAP $132,635,212 As of June 30, 2026 —
      HYPE tokens earned from staking and validating activities 11.1K Q2'26 —
      Multiple vs. Staking Yield non-GAAP 2.2 Q2'26 —
      DeFi Monetization non-GAAP $245K Q1’26 —
      Ecosystem Rewards non-GAAP $150K Q1’26 —
      Staking Yield non-GAAP $313K Q1’26 —
      Validator Commissions non-GAAP $40K Q1’26 —
      Yield Enhancement non-GAAP $211K Q1’26 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Biotechnology — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      HYPD
      Hyperion Defi, Inc.
      this stock
      		$49.42M -8.4% +1318.8% — 10.0%
      VRTX
      Vertex Pharmaceuticals Inc / Ma
      		 $138.79B +20.8% +46.2% 31.9 1.6%
      REGN
      Regeneron Pharmaceuticals, Inc.
      		 $85.30B +7.3% +20.8% 20.5 3.3%
      ARGX
      Argenx SE
      		 $64.66B +20.2% — — 2.1%
      CSLLY
      Csl Ltd
      		 $57.97B — — — 0.0%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      33
      % held
      16.2%
      Net QoQ
      +1.3M sh
      Top holder
      VANGUARD CAPITAL MANAGEME…
      Held Float
      View
      Held by Funds
      Fund positions
      8
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      1.6M
      Days to cover
      6.4d
      Change
      +28.1K sh
      View
      Short Volume
      Short vol %
      50%
      As of
      Aug 24, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      2.6K
      Value
      $6.4K
      As of
      Jul 27, 2026
      View
      Off-Exchange
      Off-exchange %
      53.2%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$29.6K
      Buyers / Sellers
      1 / 0
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $813.5K
      Net income (FY)
      $-45.3M
      EPS diluted
      $-9.40
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 13, 2026
      This year
      12
      View
      Proposed Sales
      Value
      $17.5K
      Shares
      1.4K
      Filed
      Jul 22, 2025
      View
      Exempt Offerings
      Offering
      $50.0M
      Filed
      Jul 22, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 12, 2026
      View

      Performance

      Raw-price comparisons begin at the captured split on Feb 3, 2025; windows that need an earlier baseline remain unavailable.

      5D 20D 120D MTD YTD
      HYPD +14.8% +27.3% +8.3% +23.5% -8.4%
      SPY -1.2% +3.3% +12.2% +2.2% +12.0%
      vs SPY +16.0% +24.0% -3.9% +21.3% -20.4%
      Key facts CIK 1682639 CUSIP 30234E203 13F (30d) 31 filings 31 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)